BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21370936)

  • 1. An altered peptide ligand corresponding to a novel epitope from heat-shock protein 60 induces regulatory T cells and suppresses pathogenic response in an animal model of adjuvant-induced arthritis.
    Dominguez Mdel C; Lorenzo N; Barbera A; Darrasse-Jeze G; Hernández MV; Torres A; Hernández I; Gil R; Klatzmann D; Padrón G
    Autoimmunity; 2011 Sep; 44(6):471-82. PubMed ID: 21370936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4+ CD25+ T cells from peripheral blood of rheumatoid arthritis patients.
    Barberá A; Lorenzo N; Garrido G; Mazola Y; Falcón V; Torres AM; Hernández MI; Hernández MV; Margry B; de Groot AM; van Roon J; van der Zee R; Broere F; van Eden W; Padrón G; Domínguez Mdel C
    Int Immunopharmacol; 2013 Dec; 17(4):1075-83. PubMed ID: 24177275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope.
    Prakken BJ; Roord S; van Kooten PJ; Wagenaar JP; van Eden W; Albani S; Wauben MH
    Arthritis Rheum; 2002 Jul; 46(7):1937-46. PubMed ID: 12124879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of an altered peptide ligand derived from heat-shock protein 60 by suppressing of inflammatory cytokines secretion in two animal models of rheumatoid arthritis.
    Lorenzo N; Barberá A; Domínguez MC; Torres AM; Hernandez MV; Hernandez I; Gil R; Ancizar J; Garay H; Reyes O; Altruda F; Silengo L; Padrón G
    Autoimmunity; 2012 Sep; 45(6):449-59. PubMed ID: 22686732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APL-1, an altered peptide ligand derived from heat-shock protein, alone or combined with methotrexate attenuates murine collagen-induced arthritis.
    Lorenzo N; Altruda F; Silengo L; Del Carmen Dominguez M
    Clin Exp Med; 2017 May; 17(2):209-216. PubMed ID: 27160252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
    Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Delgado M
    Arthritis Rheum; 2006 Mar; 54(3):864-76. PubMed ID: 16508968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
    González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
    Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bystander suppression of experimental arthritis by nasal administration of a heat shock protein peptide.
    Zonneveld-Huijssoon E; Roord ST; de Jager W; Klein M; Albani S; Anderton SM; Kuis W; van Wijk F; Prakken BJ
    Ann Rheum Dis; 2011 Dec; 70(12):2199-206. PubMed ID: 21914624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered collagen II 263-272 peptide immunization induces inhibition of collagen-induced arthritis through a shift toward Th2-type response.
    Li R; Li X; Li Z
    Tissue Antigens; 2009 Apr; 73(4):341-7. PubMed ID: 19317744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein.
    Quintana FJ; Carmi P; Mor F; Cohen IR
    Arthritis Rheum; 2004 Nov; 50(11):3712-20. PubMed ID: 15529360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANTI-CD3 therapy expands the numbers of CD4+ and CD8+ Treg cells and induces sustained amelioration of collagen-induced arthritis.
    Notley CA; McCann FE; Inglis JJ; Williams RO
    Arthritis Rheum; 2010 Jan; 62(1):171-8. PubMed ID: 20039431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR9 agonist CpG enhances protective nasal HSP60 peptide vaccine efficacy in experimental autoimmune arthritis.
    Zonneveld-Huijssoon E; van Wijk F; Roord S; Delemarre E; Meerding J; de Jager W; Klein M; Raz E; Albani S; Kuis W; Boes M; Prakken BJ
    Ann Rheum Dis; 2012 Oct; 71(10):1706-15. PubMed ID: 22562976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dual action of rheumatoid arthritis synovial fibroblast IL-15 expression on the equilibrium between CD4+CD25+ regulatory T cells and CD4+CD25- responder T cells.
    Benito-Miguel M; García-Carmona Y; Balsa A; Pérez de Ayala C; Cobo-Ibáñez T; Martín-Mola E; Miranda-Carús ME
    J Immunol; 2009 Dec; 183(12):8268-79. PubMed ID: 20007590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis.
    van Puijvelde GH; van Es T; van Wanrooij EJ; Habets KL; de Vos P; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2677-83. PubMed ID: 17901374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of T cells recognizing an epitope of heat-shock protein 70 can protect against rat adjuvant arthritis.
    Tanaka S; Kimura Y; Mitani A; Yamamoto G; Nishimura H; Spallek R; Singh M; Noguchi T; Yoshikai Y
    J Immunol; 1999 Nov; 163(10):5560-5. PubMed ID: 10553084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential mycobacterial 65-kDa heat shock protein T cell epitope recognition after adjuvant arthritis-inducing or protective immunization protocols.
    Anderton SM; van der Zee R; Noordzij A; van Eden W
    J Immunol; 1994 Apr; 152(7):3656-64. PubMed ID: 8144941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of experimental rheumatoid arthritis with low-dose methotrexate by increasing partially CD4+CD25+ Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
    Xinqiang S; Fei L; Nan L; Yuan L; Fang Y; Hong X; Lixin T; Juan L; Xiao Z; Yuying S; Yongzhi X
    Biomed Pharmacother; 2010 Sep; 64(7):463-71. PubMed ID: 20359858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of T cell function by combination of epitope specific and low dose anticytokine therapy controls autoimmune arthritis.
    Roord ST; Zonneveld-Huijssoon E; Le T; Yung GP; Koffeman E; Ronaghy A; Ghahramani N; Lanza P; Billetta R; Prakken BJ; Albani S
    PLoS One; 2006 Dec; 1(1):e87. PubMed ID: 17183718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cells against the pathogenic and protective epitopes of heat-shock protein 65 are crossreactive and display functional similarity: novel aspect of regulation of autoimmune arthritis.
    Durai M; Kim HR; Bala KK; Moudgil KD
    J Rheumatol; 2007 Nov; 34(11):2134-43. PubMed ID: 17937454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.